9/8/2010
STAAR Surgical Company , the leading worldwide developer, manufacturer and marketer of phakic intraocular lenses, today announced that the Visian Implantable CollamerĀ® Lens (ICL) was featured prominently in more than 40 presentations by leading ophthalmologists at meetings prior to and during the 2010 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) held in Paris, France from September 4 through 8, 2010. The presentations, based on studies conducted by surgeons throughout the world, confirmed that the Visian ICL offers superior visual results over a wide range of myopic and hyperopic refractive errors including those within the most popular LASIK areas of treatment. These presentations also confirmed the safety and efficacy of the Visian ICL over a period of 17 years.
Source:
STAAR Surgical Company